Partnerships

Pharmaxon is a translational research company whose added value lies in its capacity to discover, characterise and develop molecular targets specifically involved in controlling cell mobility.

This pursuit for new targets is sustained in-house by the company’s high-content screening platform and externally via collaboration with members of its scientific network. Though the company expects to retain its commercial rights on its drugs, it intends to sign partnerships with the biopharmaceutical industry as early on in the process as possible so this new therapeutic option is open to patients as quickly as possible.